SKNV Launches Kefunova™, a Custom Formulated 5-FU Prescription Medication
Hand-out
Press Releases
May 1, 2025

SKNV Launches Kefunova™, a Custom Formulated 5-FU Prescription Medication

A Direct Response to Provider Demand for Advanced Actinic Keratosis Therapy and Superficial Basal Cell Carcinoma

bradford

The Bradford Era

Local & Social